|
|
Clinical effect of narrow-band intense pulsed light combined with Timolol in the treatment of patients with mild to moderate acne |
JIANG Jieyao HUA Yunhui LI Zihai YAN Ning CHEN Wei YU Xiaoyun▲ |
Department of Dermatology, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine Nanjing Second Hospital, Jiangsu Province, Nanjing 210003, China |
|
|
Abstract Objective To explore the clinical effect of narrow-band intense pulsed light (DPL) combined with Timolol in the treatment of patients with mild to moderate acne. Methods A total of 102 patients with mild to moderate acne admitted to the Nanjing Hospital Affiliated to Nanjing University of Chinese Medicinel from January 2019 to May 2021 were selected as the research objects, and they were divided into combination group (51 cases) and control group (51 cases) according to the random number table method. The control group were treated with DPL, and the combination group were treated with Timolol on the basis of the control group. The clinical efficacy of the two groups after 12 weeky of treatments was compared, the acne-specific quality of life questionnaire (Acne-QOL), serum interleukin 1α (IL-1α) levels were compared between the two groups before and after treatment. The incidence of adverse reactions during treatment in the two groups was recorded. Results The clinical efficacy of the combination group was better than that of the control group, and the difference was statistically significant (P < 0.05). Before treatment, there was no significant difference in Acne-QOL scores between the two groups (P > 0.05), after treatment, the Acne-QOL scores of the two groups were higher than those before treatment, and the combination group was higher than the control group, the differences were statistically significant (P < 0.05). Before treatment, there was no significant difference in serum IL-1α levels between the two groups (P > 0.05), after treatment, serum IL-1α levels in the two groups were lower than those before treatment, and the combination group was lower than the control group, the differences were statistically significant (P < 0.05). There was no significant difference in the total incidence of complications between the two groups (P > 0.05). Conclusion DPL combined with Timolol has a definite effect in the treatment of patients with mild to moderate acne. It can improve the quality of life of patients, reduce the inflammation of the body, and it is safe and reliable.
|
|
|
|
|
[1] 阳熙照,唐言,李吉,等.单用功效性护肤品治疗轻中度面部玫瑰痤疮及脂溢性皮炎的多中心临床研究[J].医学临床研究,2021,38(1):43-46,50.
[2] 王亚玲,赵志祥,刘芳芬,等.中国人群玫瑰痤疮发病与饮酒、吸烟的关系[J].中南大学学报(医学版),2020,45(2):165-168.
[3] 王芳,颜金花.化脓性无菌性关节炎坏疽性脓皮病和痤疮综合征发病机制及诊治相关研究进展[J].中华风湿病学杂志,2020,24(10):709-714.
[4] 中华医学会皮肤性病学分会玫瑰痤疮研究中心,中国医师协会皮肤科医师分会玫瑰痤疮专业委员会.中国玫瑰痤疮诊疗指南(2021版)[J].中华皮肤科杂志,2021,54(4):279-288.
[5] 党辉,李微,马瑛. m22强脉冲光联合595nm染料激光治疗寻常痤疮临床观察[J].中国美容医学,2021,30(9):107-111.
[6] 仲少敏,吴艳.寻常性痤疮诊断和治疗的新动向[J].中国美容医学,2020,29(3):1-3.
[7] 张添龙,欧阳玲,宋维芳.小剂量盐酸米诺环素联合窄谱强脉冲光治疗玫瑰痤疮的效果研究[J].中国医刊,2020, 55(9):1017-1019.
[8] 唐帮丽,丁钰,易清玲,等.窄谱强脉冲光联合重组人表皮生长因子凝胶治疗面部痤疮瘢痕疗效分析[J].中国美容医学,2020,29(1):41-45.
[9] 施伟伟,花志祥,范向华,等.窄谱强脉冲光治疗面部痤疮后红斑临床疗效探讨[J].中国美容医学,2019,28(11):50-52.
[10] 夏学颖,孙赛,张碧芳,等.马来酸噻吗洛尔滴眼液联合强脉冲光治疗婴幼儿表浅血管瘤的疗效观察[J].中国医药科学,2017,7(12):28-31,89.
[11] 赵蓓,周夕湲,梁成琳,等.马来酸噻吗洛尔治疗血管瘤的作用机制探讨[J].实用医院临床杂志,2021,18(3):54-56.
[12] Afra TP, Razmi TM,De D. Topical timolol for postacne erythema [J]. J Am Acad Dermatol,2021,84(6):e255-e256.
[13] 李若瑜.皮肤病学与性病学[M].北京:北京大学医学出版社,2010:155-156.
[14] 中国医师协会皮肤科医师分会皮肤美容亚专业委员会.中国玫瑰痤疮诊疗专家共识(2016)[J].中华皮肤科杂志,2017,50(3):156-161.
[15] 廖伏翠,刘琴,严月华,等.面部痤疮对大学生生活质量的影响[J].中华现代护理杂志,2014,20(31):3942-3944.
[16] 张小蒙,周敏,商干伟,等.红蓝光联合药物系统治疗中重度痤疮的临床疗效[J].江苏医药,2016,42(6):698-699.
[17] 莫俊熙,黄咏菁,禤国维,等.国医大师禤国维运用二至丸治疗皮肤病经验撷要[J].中国医药导报,2021,18(8):141-144.
[18] 续凤凤,郎小青,郭书萍.痤疮的治疗进展[J].中国临床研究,2020,33(5):700-702.
[19] 周书帆,文丽萍,杜宇.超分子水杨酸联合窄谱强脉冲光治疗玫瑰痤疮临床疗效观察[J].中国美容医学,2019,28(2):48-52.
[20] 梁锐炯,黄桃源.二氧化碳点阵激光联合优创硅酮敷料治疗面部痤疮瘢痕的疗效观察[J].中国医药科学,2020, 10(3):288-290.
[21] 蔡杏仪,张方布.窄谱强脉冲激光联合克痤隐酮凝胶治疗炎症性痤疮的临床效果[J].中国当代医药,2020,27(6):57-59.
[22] 吴书,张开颜,陈炳荣,等.拉坦前列素与噻吗洛尔不同联用方案治疗原发性开角型青光眼的临床观察[J].中国药房,2018,29(6):809-812.
[23] 孙欣荣,刘志宏,黄爱文,等.痤疮发病机制及其药物治疗的研究进展[J].中国药房,2017,28(20):2868-2871.
[24] 郭焕焕,张文学.痤疮发病机制及对青少年的影响[J].生物学教学,2017,42(2):4-5.
[25] 白瑞雪,接丽莉,杨跃辉.马来酸噻吗洛尔胶浆剂制备及其体外透皮特性研究[J].药学与临床研究,2021,29(4):283-285.
[26] 余丰文,刘德军,冯彦林,等.90Sr- 90Y小剂量敷贴与噻吗洛尔局部外用及其联合应用治疗浅表型婴幼儿血管瘤的前瞻性队列研究[J].中华核医学与分子影像杂志,2021,41(5):280-285.
[27] 赵峰,尹瑞瑞,吕洁,等.目标策略性干预应用于婴儿血管瘤治疗中的效果观察[J].中国医药,2020,15(6):945-948.
[28] 李兴红,李晨曦,凌彬,等.局部外用噻吗洛尔与口服普萘洛尔治疗表浅型婴幼儿血管瘤效果对比的Meta分析[J].口腔颌面外科杂志,2021,31(2):90-96.
[29] 叶雯霞,金宛宛,全和和,等.595 nm染料激光联合外用0.5%马来酸噻吗洛尔溶液治疗浅表型的疗效评价[J].中华皮肤科杂志,2018,51(12):888-892. |
|
|
|